Sfoglia per Rivista
Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial.
2002-01-01 Dallorso, S; Rondelli, R; Messina, C; Pession, A; Giorgiani, G; Fagioli, F; Locatelli, Franco; Manzitti, C; Balduzzi, A; Prete, A; Cesaro, S; Lanino, E; Dini, G.
Clinical evaluation of erythrocyte zinc-protoporphyrin as a parameter of iron status in man.
1984-01-01 Bellotti, Vittorio; Bergamaschi, G.; Caldera, D.; Cazzola, Mario; Ciriello, M. M.; Colotti, M. T.; Dezza, L.; Melzi D'Eril, G.; Quaglini, Silvana
CLINICAL EVALUATION OF ERYTROCYTE ZINC-PROTOPORPHYRIN AS A PARAMETER OF IRON STATUS IN MAN.
1984-01-01 Bellotti, Vittorio; Bergamaschi, G; Caldera, D; Cazzola, Mario; Ciriello, Mm; Colotti, Mt; Dezza, L; MELZI D'ERIL, G; Quaglini, Silvana
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools.
2012-01-01 DELLA PORTA, MATTEO GIOVANNI; I., Ambaglio; M., Ubezio; E., Travaglino; C., Pascutto; Malcovati, Luca
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
2012-01-01 Broseus, J; Florensa, L; Zipperer, E; Schnittger, S; Malcovati, Luca; Richebourg, S; Lippert, E; Cermak, J; Evans, J; Mounier, M; Raya, Jm; Bailly, F; Gattermann, N; Haferlach, T; Garand, R; Allou, K; Besses, C; Germing, U; Haferlach, C; Travaglino, E; Luno, E; Pinan, Ma; Arenillas, L; Rozman, M; Perez Sirvent, Ml; Favre, B; Guy, J; Alonso, E; Ahwij, N; Jerez, A; Hermouet, S; Maynadie', M; Cazzola, Mario; Girodon, F.
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group
2015-01-01 D’Angiò, Mariella; Valsecchi, Maria G.; Testi, Anna M.; Conter, Valentino; Nunes, Vittorio; Parasole, Rosanna; Colombini, Antonella; Santoro, Nicola; Varotto, Stefania; Caniglia, Maurizio; Silvestri, Daniela; Consarino, Caterina; Levati, Laura; Magrin, Elisa; Locatelli, Franco; Basso, Giuseppe; Foà, Robin; Biondi, Andrea; Cazzaniga, Gianni
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
2009-01-01 Morra, E; Barosi, G; Bosi, A; Ferrara, F; Locatelli, Franco; Marchetti, M; Martinelli, G; Mecucci, C; Vignetti, M; Tura, S.
Clinical phenotypes, immunologic evaluation and molecular analysis in patients affected by X-recessive isolated thrombocytopenia
2008-01-01 Notarangelo, L. D.; Giliani, S.; Moratto, D.; Mazza, C.; Soresina, A.; D'Ippolitc, C.; Tettoni, K.; Soresina, R.; Verdoni, L.; Ricci, F.; Meda, S. V.; Noris, Patrizia; Jankovic, M.; Ladogana, S.; Cossu, F.; De Mattia, D.; Notarangelo, L. D.; Porta, F.
Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome.
2009-01-01 DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca
Clinical relevance of JAK2 (V617F) mutant allele burden
2009-01-01 Passamonti, Francesco; Rumi, Elisa
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure
1985-01-01 Carlo Stella, C; Ghizzi, A; Pedrazzoli, P; Gorini, M; Ascari, E
Clinical results in 2001 show high dose therapy and hematopoietic progenitor cell transplantation as a therapeutic option for breast cancer
2001-01-01 Pedrazzoli, P; Siena, S
Clinical spectrum of porphyria cutanea tarda.
1999-01-01 Borroni, Giovanni; Chiesa, Mg; Vassallo, C; Ardigò, M; G., Borroni
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow
1998-01-01 Arcese, W; F., Aversa; G., Bandini; A., DE VINCENTIIS; M., Falda; L., Lanata; R. M., Lemoli; Locatelli, Franco; I., Majolino; P., Zanon; S., Tura
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
2003-01-01 Passamonti, Francesco; Vanelli, L; Malabarba, L; Rumi, Elisa; Pungolino, E; Malcovati, Luca; Pascutto, Cristiana; Morra, E; Lazzarino, Mario; Cazzola, Mario
CLINICAL-MOLECULAR PREDICTORS OF THROMBOCYTOPENIA AND RISK OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 2B: A PROSPECTIVE STUDY IN A COHORT OF 67 PATIENTS
2008-01-01 Federici, A. B.; Baronciani, L.; Castaman, G.; Mannucci, P. M.; Canciani, M. T.; Bucciarelli, P.; Pecci, Alessandro; Lenting, P. L.; De Groot, P. G.
CLINICAL-MOLECULAR PREDICTORS OF THROMBOCYTOPENIA AND RISK OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 2B: A PROSPECTIVE STUDY IN A COHORT OF 67 PATIENTS.
2008-01-01 La, M. S.; Rubini, V.; Punzo, M.; Cozzi, G.; Canciani, M. T.; Baronciani, L.; Mannucci, P. M.; Castaman, G.; Pecci, Alessandro; Lenting, P. J.; De Groot, P. G.; Federici, A. B.
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy
2004-01-01 Breccia, M; Diverio, D; Noguera, Ni; Visani, G; Santoro, A; Locatelli, Franco; Damiani, D; Marmont, F; Vignetti, M; Petti, Mc; LO COCO, F.
Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498).
2008-01-01 Maserati, E; Panarello, C; Morerio, C; Valli, R; Pressato, B; Patitucci, F; Tassano, E; Di Cesare Merlone, A; Cugno, C; Balduini, Carlo; Lo Curto, F; Dufour, C; Locatelli, Franco; Pasquali, F.
Clotting alterations in primary systemic amyloidosis
2000-01-01 Gamba, Gabriella; Montani, MARIA NADIA; Anesi, E; Palladini, Giovanni; Capezzera, M; Soldavini, E; Merlini, Giampaolo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial. | 1-gen-2002 | Dallorso, S; Rondelli, R; Messina, C; Pession, A; Giorgiani, G; Fagioli, F; Locatelli, Franco; Manzitti, C; Balduzzi, A; Prete, A; Cesaro, S; Lanino, E; Dini, G. | |
Clinical evaluation of erythrocyte zinc-protoporphyrin as a parameter of iron status in man. | 1-gen-1984 | Bellotti, Vittorio; Bergamaschi, G.; Caldera, D.; Cazzola, Mario; Ciriello, M. M.; Colotti, M. T.; Dezza, L.; Melzi D'Eril, G.; Quaglini, Silvana | |
CLINICAL EVALUATION OF ERYTROCYTE ZINC-PROTOPORPHYRIN AS A PARAMETER OF IRON STATUS IN MAN. | 1-gen-1984 | Bellotti, Vittorio; Bergamaschi, G; Caldera, D; Cazzola, Mario; Ciriello, Mm; Colotti, Mt; Dezza, L; MELZI D'ERIL, G; Quaglini, Silvana | |
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. | 1-gen-2012 | DELLA PORTA, MATTEO GIOVANNI; I., Ambaglio; M., Ubezio; E., Travaglino; C., Pascutto; Malcovati, Luca | |
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis | 1-gen-2012 | Broseus, J; Florensa, L; Zipperer, E; Schnittger, S; Malcovati, Luca; Richebourg, S; Lippert, E; Cermak, J; Evans, J; Mounier, M; Raya, Jm; Bailly, F; Gattermann, N; Haferlach, T; Garand, R; Allou, K; Besses, C; Germing, U; Haferlach, C; Travaglino, E; Luno, E; Pinan, Ma; Arenillas, L; Rozman, M; Perez Sirvent, Ml; Favre, B; Guy, J; Alonso, E; Ahwij, N; Jerez, A; Hermouet, S; Maynadie', M; Cazzola, Mario; Girodon, F. | |
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group | 1-gen-2015 | D’Angiò, Mariella; Valsecchi, Maria G.; Testi, Anna M.; Conter, Valentino; Nunes, Vittorio; Parasole, Rosanna; Colombini, Antonella; Santoro, Nicola; Varotto, Stefania; Caniglia, Maurizio; Silvestri, Daniela; Consarino, Caterina; Levati, Laura; Magrin, Elisa; Locatelli, Franco; Basso, Giuseppe; Foà, Robin; Biondi, Andrea; Cazzaniga, Gianni | |
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation. | 1-gen-2009 | Morra, E; Barosi, G; Bosi, A; Ferrara, F; Locatelli, Franco; Marchetti, M; Martinelli, G; Mecucci, C; Vignetti, M; Tura, S. | |
Clinical phenotypes, immunologic evaluation and molecular analysis in patients affected by X-recessive isolated thrombocytopenia | 1-gen-2008 | Notarangelo, L. D.; Giliani, S.; Moratto, D.; Mazza, C.; Soresina, A.; D'Ippolitc, C.; Tettoni, K.; Soresina, R.; Verdoni, L.; Ricci, F.; Meda, S. V.; Noris, Patrizia; Jankovic, M.; Ladogana, S.; Cossu, F.; De Mattia, D.; Notarangelo, L. D.; Porta, F. | |
Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome. | 1-gen-2009 | DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca | |
Clinical relevance of JAK2 (V617F) mutant allele burden | 1-gen-2009 | Passamonti, Francesco; Rumi, Elisa | |
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure | 1-gen-1985 | Carlo Stella, C; Ghizzi, A; Pedrazzoli, P; Gorini, M; Ascari, E | |
Clinical results in 2001 show high dose therapy and hematopoietic progenitor cell transplantation as a therapeutic option for breast cancer | 1-gen-2001 | Pedrazzoli, P; Siena, S | |
Clinical spectrum of porphyria cutanea tarda. | 1-gen-1999 | Borroni, Giovanni; Chiesa, Mg; Vassallo, C; Ardigò, M; G., Borroni | |
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow | 1-gen-1998 | Arcese, W; F., Aversa; G., Bandini; A., DE VINCENTIIS; M., Falda; L., Lanata; R. M., Lemoli; Locatelli, Franco; I., Majolino; P., Zanon; S., Tura | |
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. | 1-gen-2003 | Passamonti, Francesco; Vanelli, L; Malabarba, L; Rumi, Elisa; Pungolino, E; Malcovati, Luca; Pascutto, Cristiana; Morra, E; Lazzarino, Mario; Cazzola, Mario | |
CLINICAL-MOLECULAR PREDICTORS OF THROMBOCYTOPENIA AND RISK OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 2B: A PROSPECTIVE STUDY IN A COHORT OF 67 PATIENTS | 1-gen-2008 | Federici, A. B.; Baronciani, L.; Castaman, G.; Mannucci, P. M.; Canciani, M. T.; Bucciarelli, P.; Pecci, Alessandro; Lenting, P. L.; De Groot, P. G. | |
CLINICAL-MOLECULAR PREDICTORS OF THROMBOCYTOPENIA AND RISK OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 2B: A PROSPECTIVE STUDY IN A COHORT OF 67 PATIENTS. | 1-gen-2008 | La, M. S.; Rubini, V.; Punzo, M.; Cozzi, G.; Canciani, M. T.; Baronciani, L.; Mannucci, P. M.; Castaman, G.; Pecci, Alessandro; Lenting, P. J.; De Groot, P. G.; Federici, A. B. | |
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy | 1-gen-2004 | Breccia, M; Diverio, D; Noguera, Ni; Visani, G; Santoro, A; Locatelli, Franco; Damiani, D; Marmont, F; Vignetti, M; Petti, Mc; LO COCO, F. | |
Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). | 1-gen-2008 | Maserati, E; Panarello, C; Morerio, C; Valli, R; Pressato, B; Patitucci, F; Tassano, E; Di Cesare Merlone, A; Cugno, C; Balduini, Carlo; Lo Curto, F; Dufour, C; Locatelli, Franco; Pasquali, F. | |
Clotting alterations in primary systemic amyloidosis | 1-gen-2000 | Gamba, Gabriella; Montani, MARIA NADIA; Anesi, E; Palladini, Giovanni; Capezzera, M; Soldavini, E; Merlini, Giampaolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile